Swiss Medical Regulatory
International Coalition of Medicines Regulatory Authorities (ICMRA)
The International Coalition of Medicines Regulatory Authorities (ICMRA) is a strategic coordinating entity for regulatory authorities, enhancing global communication, information sharing, and crisis response for medicines.
The International Coalition of Medicines Regulatory Authorities (ICMRA) is a voluntary, executive-level entity focused on strategic coordination, advocacy, and leadership among regulatory authorities. Its mission is to provide a global architecture that supports enhanced communication, information sharing, and crisis response, while also addressing regulatory science issues. ICMRA aims to tackle current and emerging human medicine regulatory and safety challenges on a global scale. The organization is designed to facilitate collaboration and streamline responses to critical issues within the field of medicine regulation. The website itself was designed by Swissmedic and is maintained by the Pharmaceuticals and Medical Devices Agency, indicating a collaborative effort in its operational infrastructure.
About
**Who they are**
Swiss Medical Regulatory is a strategic coordinating entity for regulatory authorities, enhancing global communication, information sharing, and crisis response for medicines. The organization is involved in addressing regulatory science issues and common challenges in human medicine regulation and safety globally.
**Expertise & scope**
* Facilitates global communication and information sharing among medicines regulatory authorities.
* Enhances crisis response capabilities for medicines.
* Addresses current and emerging human medicine regulatory and safety challenges strategically on a global scale.
* Supports the regulation of therapeutic goods, including the control of drug imports, exports, and production.
**Reputation / proof points**
* The website was designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency.
Swiss Medical Regulatory is a strategic coordinating entity for regulatory authorities, enhancing global communication, information sharing, and crisis response for medicines. The organization is involved in addressing regulatory science issues and common challenges in human medicine regulation and safety globally.
**Expertise & scope**
* Facilitates global communication and information sharing among medicines regulatory authorities.
* Enhances crisis response capabilities for medicines.
* Addresses current and emerging human medicine regulatory and safety challenges strategically on a global scale.
* Supports the regulation of therapeutic goods, including the control of drug imports, exports, and production.
**Reputation / proof points**
* The website was designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency.
Additional information
The International Coalition of Medicines Regulatory Authorities (ICMRA) operates as a key forum for regulatory bodies. Its activities focus on collaborative efforts to manage and improve the regulation of medicines worldwide. The organization's structure includes a Chair, who leads strategic initiatives and governance. ICMRA also engages with participating regulatory authorities, associate members, and observers to foster a coordinated approach to global health challenges.
Key Highlights
-
The International Coalition of Medicines Regulatory Authorities (ICMRA) is a strategic coordinating entity for regulatory authorities.
Source
“The International Coalition of Medicines Regulatory Authorities (ICMRA) is a strategic coordinating entity for regulatory authorities, enhancing global communication, information sharing, and crisis response for medicines.”
-
ICMRA addresses current and emerging human medicine regulatory and safety challenges globally.
Source
“address current and emerging human medicine regulatory and safety challenges globally, strategically”
-
The website was designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency.
Source
“Website designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency”
Certifications & Trust Signals
-
ICMRA facilitates global communication, information sharing, and crisis response for medicines.
Source
“enhancing global communication, information sharing, and crisis response for medicines.”
Buyer Snapshot
Best for
- Global regulatory coordination for medicines
- Information sharing among authorities
How engagement typically works
- Collaborative
- Information exchange
Typical deliverables
- Enhanced global communication strategies
- Improved crisis response frameworks
- Strategic guidance on regulatory challenges
Good to know
- Best when engaging with international regulatory bodies
HQ:
Geneva, Switzerland
Languages:
English, German, French
Timezones:
Europe/Zurich
Status:
listed
Services & Capabilities
Best CH-REP (Swiss Authorized Rep) | Compare & Get Quotes
Jurisdictions:
CH
Countries:
CH
Industries:
Medical devices, IVD
Portfolio:
6-25
Onboarding time:
3–10 days
Pricing model:
Custom pricing
Starting from:
CHF 2,100
Included services:
Swissmedic contact point handling, Vigilance and incident reporting coordination, Labeling/packaging CH-REP information alignment, Mandate administration and documentation availability
Swiss Local Contact:
No
Labeling Support:
No
Can Be Named On Label:
No
Vigilance Contact Support:
No
Additional ch_rep Details
Supports MDR
true
Supports IVDR
true
Swiss Entity Canton Or Region
CH
Labeling Support
true
Swiss Local Contact
true
Vigilance Contact Support
true
Can Be Named On Label
true
